DAVOS, Switzerland (Reuters) – Roche Holding AG's rivals Sanofi SA and Novartis AG see no need to match the Swiss drugmaker in buying a gene-decoding business like Illumina Inc and reckon they can do partnerships instead. The relaxed attitude in the face of Roche's $5.7 billion hostile bid for Illumina suggests the chance of a counterbid from big drugmakers is slim, although diagnostics and IT …

Read more here:
Rivals see no need to match Roche's big gene bet

In diseases like muscular dystrophy [1] or a heart attack [2] , “ muscle [3] begins to die and undergoes its normal wounding processes,” said Engler, a bioengineering [4] professor at the Jacobs School of Engineering at UC San Diego. “This damaged tissue is fundamentally different from a mechanical perspective” than healthy tissue.

Read more from the original source:
Need muscle for a tough spot? Turn to fat stem cells

Researchers at Queen’s University believe they have discovered what causes the loss of a tumour-suppressing gene in aggressive cases of prostate cancer. Dr.

Continue reading here:
Researchers make key finding in loss of tumour-fighting gene

18-01-2012 03:45 Tonight on the Tuesday, January 17, 2012 edition of the Infowars Nightly News: • Alex interviews Infowars contributing writer and vaccine researcher Curt Linderman Sr. about the medical tyranny hoax that ceaseless continues in trying to trick the public into complying with “mandatory” vaccinations. In the latest episode, a Pennsylvanian doctor reported her patient to a state trooper, as well as Children and Youth Services Department, after the mother, Rachel Garmon, refused dangerous inoculations for her son.

Read more:
Medical Tyranny: Infowars Nightly News – Video

Medical researchers reports that newly discovered mutations in an evolved assembly of genes cause Joubert syndrome, a form of syndromic autism.

Read more:
Scientists link evolved, mutated gene module to syndromic autism

by JEAN ENERSEN / KING 5 News Bio [1] | Email [2] | Follow: @jeanenersen KING5.com Posted on January 26, 2012 at 5:31 PM Updated today at 5:47 PM Scientists believe stem cells could hold the key to the treatment and cure of more than 70 major diseases and conditions.

More:
Medicine's next big thing could just be skin deep

19-01-2012 22:48 Stem cell research has the potential to yield groundbreaking new tools to understand and develop therapies for CP and related brain disorders.

Original post:
Professor Alan Trounson – World focus on stem cell research – Video

Brain cells from Alzheimer's patients have been grown in a highly purified form by San Diego and international scientists, producing models of the increasingly common neurodegenerative disease suitable for testing drugs.

Go here to read the rest:
Alzheimer's brain cells grown from patients' skin cells could model disease

Researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility that therapies for bone disorders could help in the treatment of leukemia.

See original here:
Leukemia cells are 'bad to the bone', research finds

A brother with autism or a grandmother with depression could help determine which subjects you find intellectually engaging, according to new research that reveals a link between family psychiatric history and interests.

Read this article:
Family's Mental Disorders May Shape Your Interests

University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility that therapies for bone disorders could help in the treatment of leukemia.

See the original post:
Study finds leukemia cells are 'bad to the bone'

Officials at the Texas Heart Institute at St.

The rest is here:
World-Renowned Cell-Therapy Researcher, Doris Taylor, PhD, Joins Texas Heart Institute at St. Luke’s Episcopal Hospital

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced interim results from 32 patients treated to date in a phase I clinical trial of ADCETRIS administered in combination with or sequentially with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma and other CD30-positive mature T-cell lymphoma patients.

Link:
Seattle Genetics and Millennium Report Data from Phase I Trial of ADCETRIS™ in Front-line Mature T-Cell Lymphomas

SAN FRANCISCO–(BUSINESS WIRE)– Seattle Genetics, Inc.

See the original post here:
Seattle Genetics Announces Data from ADCETRIS™ in Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

( University of Rochester Medical Center ) University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility that therapies for bone disorders could help in the treatment of leukemia.

See the article here:
URMC finds leukemia cells are 'bad to the bone'

TORONTO – Doctors have performed Ontario's first cardiac stem cell transplant using cells from the patient's own bone marrow.

More:
Researchers hope cardiac stem cell transplants may help heart failure patients

Some heart bypass patients are receiving cardiac stem cell transplants to try to repair damage.

Read more from the original source:
Heart patient's stem cells harnessed for healing

Researchers at Queen's University in Kingston, Canada have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer.

More:
New research sheds light on gene destruction linked to aggressive prostate cancer

( Queen's University ) Researchers at Queen's University in Kingston, Canada have identified a possible cause for the loss of a tumor suppressor gene that can lead to the development of more aggressive forms of prostate cancer.

Continue reading here:
New Queen's University research sheds light on gene destruction linked to aggressive prostate cancer

Paper in The Lancet Neurology states intrapartum, postnatal conditions less of a factor than genetics.

Read more:
Genetic Abnormalities May Cause Cerebral Palsy

Heart failure is a leading cause of death in Canada. As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first cardiac stem cell transplant in Ontario last week using stem cells derived from the patient's own bone marrow, isolated completely within the operating room, and implanted into the heart at the time …

Read more:
Ontario's first cardiac stem cell transplant performed last week

( Mary Ann Liebert, Inc./Genetic Engineering News ) Mary Ann Liebert Inc. announces the launch of its new website, offering streamlined access to over 92,000 articles from 70 high-impact publications.

Follow this link:
Mary Ann Liebert Inc. launches next-generation Web platform

Public release date: 26-Jan-2012 [ | E-mail [1] | Share [2] ] Contact: Erica DiMiao erica.dimiao@uhn.ca 416-340-4636 University Health Network [4] [3] Heart failure is a leading cause of death in Canada. As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first cardiac stem cell transplant in Ontario last week using stem cells derived from the patient's own bone marrow, isolated completely within the operating room, and implanted into the heart at the time of coronary bypass surgery.

See the article here:
Ontario's first cardiac stem cell transplant performed last week at the Peter Munk Cardiac Centre

DURHAM, NC–(Marketwire -01/26/12)- Aldagen, Inc. today announced that a poster describing the homing properties of its cellular therapies was presented at the Seventh International Conference on Cell Therapy for Cardiovascular Disease

Read the original post:
Aldagen Presents Data Describing Cell Therapy Products' Mechanism for Homing to Ischemic Injury

A Cambridge University research team has for the first time discovered a method of generating different types of vascular smooth muscle cells (SMCs) – the cells which make up the walls of blood vessels – using cells from patients' skin. This work could lead to new treatments and better screening for cardiovascular disease.

Go here to see the original:
Cambridge team first to grow smooth muscle cells from patient skin cells